Clobot Co Ltd

Clobot Co Ltd has a strong liquidity position, with cash and equivalents amounting to KRW 13,177,362,000, which represents 18% of total assets. The company's liquidity FPT (free cash flow to total assets) is not explicitly provided, but the current ratio of 6.25 indicates a robust ability to meet short-term obligations. The debt-to-equity ratio of 0.01 suggests a conservative capital structure with minimal leverage.

In terms of profitability, Clobot is currently unprofitable, with a net loss of KRW 2,150,246,090 and an operating loss of KRW 3,218,706,260. The return on equity (ROE) is -3.56%, and the return on assets (ROA) is -2.94%, both significantly below the industry median for software companies. These metrics indicate that the company is not generating returns for shareholders or effectively utilizing its assets.

Clobot's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. The company's geographic exposure is not disclosed, but given its listing in South Korea, it is likely that a significant portion of its operations and revenue are generated domestically.

The company's growth trajectory is uncertain, as no specific revenue growth rates or outlooks are provided in the available data. However, the negative operating and net income suggest that the company is not currently expanding profitably. The capital expenditure of KRW 767,945,810 indicates some investment in growth, but the negative free cash flow of KRW 1,691,989,900 suggests that these investments are not yet generating positive returns.

Clobot's risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt levels and strong cash position reduce the likelihood of near-term financial distress. However, the negative earnings and cash flow metrics suggest operational risks that could affect long-term sustainability.

Recent events and filings do not provide specific details on Clobot's operations or strategic direction. The absence of detailed disclosures may indicate a lack of transparency or a focus on internal development rather than public announcements. Investors should monitor future filings for more insight into the company's strategic initiatives and financial health.